(0.02%) 5 071.63 points
(-0.11%) 38 461 points
(0.10%) 15 713 points
(0.02%) $82.83
(1.09%) $1.671
(-0.37%) $2 329.70
(-0.50%) $27.21
(-0.50%) $911.20
(0.07%) $0.935
(0.82%) $10.99
(-0.06%) $0.803
(-0.94%) $92.31
Live Chart Being Loaded With Signals
Japan Lifeline Co., Ltd., a medical device company, develops, produces, imports, distributes, and trades in cardiovascular related medical devices in Japan...
Stats | |
---|---|
Today's Volume | 178 500 |
Average Volume | 177 016 |
Market Cap | 78.98B |
EPS | ¥0 ( 2024-02-01 ) |
Next earnings date | ( ¥0 ) 2024-05-01 |
Last Dividend | ¥38.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 10.49 |
ATR14 | ¥0.458 (0.04%) |
Volume Correlation
Japan Lifeline Co., Ltd. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Japan Lifeline Co., Ltd. Correlation - Currency/Commodity
Japan Lifeline Co., Ltd. Financials
Annual | 2022 |
Revenue: | ¥51.75B |
Gross Profit: | ¥29.90B (57.77 %) |
EPS: | ¥88.22 |
Q3 | 2023 |
Revenue: | ¥13.17B |
Gross Profit: | ¥8.07B (61.30 %) |
EPS: | ¥28.32 |
Q2 | 2023 |
Revenue: | ¥12.18B |
Gross Profit: | ¥7.34B (60.31 %) |
EPS: | ¥22.32 |
Q1 | 2023 |
Revenue: | ¥12.95B |
Gross Profit: | ¥7.89B (60.89 %) |
EPS: | ¥30.02 |
Financial Reports:
No articles found.
Japan Lifeline Co., Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥0 (N/A) |
¥38.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥3.13 | 2000-03-28 |
Last Dividend | ¥38.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 22 | -- |
Total Paid Out | ¥232.75 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.18 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.32 | |
Div. Directional Score | 8.21 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
6637.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
5959.T | Ex Dividend Junior | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
4661.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3901.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
3134.T | Ex Dividend Junior | 2024-04-26 | Annually | 0 | 0.00% | |
2004.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
8987.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
8544.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7868.T | Ex Dividend Junior | 2023-09-28 | Sporadic | 0 | 0.00% | |
7012.T | No Dividend Player | 2023-09-28 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.165 | 1.500 | 6.71 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.121 | 1.200 | 5.97 | 7.16 | [0 - 0.3] |
returnOnEquityTTM | 0.152 | 1.500 | 9.42 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 3.51 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 1.970 | 0.800 | 3.12 | 2.49 | [0.8 - 2.5] |
cashRatioTTM | 0.907 | 1.500 | 6.07 | 9.11 | [0.2 - 2] |
debtRatioTTM | 0.0591 | -1.500 | 9.01 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 405.57 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 34.12 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 34.12 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0729 | -1.500 | 9.71 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.602 | 1.000 | 3.29 | 3.29 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.220 | 1.000 | 7.59 | 7.59 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.621 | 1.000 | 7.66 | 7.66 | [0.2 - 2] |
assetTurnoverTTM | 0.734 | 0.800 | 8.44 | 6.75 | [0.5 - 2] |
Total Score | 12.11 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 10.30 | 1.000 | 9.06 | 0 | [1 - 100] |
returnOnEquityTTM | 0.152 | 2.50 | 9.63 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 34.12 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.63 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 34.12 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.0376 | 1.500 | -3.08 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0500 | 1.000 | -1.250 | 0 | [0.1 - 0.5] |
Total Score | 4.32 |
Japan Lifeline Co., Ltd.
Japan Lifeline Co., Ltd., a medical device company, develops, produces, imports, distributes, and trades in cardiovascular related medical devices in Japan. The company's cardiac rhythm management products include cardiac pacemakers, implantable cardioverter defibrillators, subcutaneous implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support devices; and electrophysiology/ablation products comprise electrophysiological and ablation catheters, irrigated tip ablation catheters, endoscopic balloon ablation systems, esophageal temperature monitoring systems, internal atrial cardioversion systems, and radio-frequency transseptal needles. Its cardiovascular and endografting products consist of vascular and open stent grafts, and abdominal stent-grafts; and transvascular intervention products include PTCA and PTA guide wires, PTCA balloon catheters, radiofrequency wires, and atrial septal defect closure devices. The company offers gastrointestinal intervention products that consist of radiofrequency ablation systems, self-expandable colonic stents, and endoscopic guidewires. Japan Lifeline Co., Ltd. was incorporated in 1981 and is headquartered in Tokyo, Japan.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators